"AMBS" - Read the recent Yahoo news.
The co-founder of Amgen and the former head of M & A for Novartis are two of the members of the company's advisory board.
The company is in a development deal with Becton Dickinson for its diagnostic test to detect early stage Alzheimer's. Potential $500,000,000 annual market.
The company's pateneted MANF drug already has two "orphan indications" with many more expected to follow.
Follow the company on Twitter: @AmarantusBio ..... 8,480 followers
Read today's Yahoo news.
News expected before the end of the quarter. Get in today at seven cents.
Most undervalued stock in the market.